MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202621097284 A) filed by Lnct University, Bhopal on August 12, 2026, for Polymeric Transdermal Drug Delivery System Incorporating Remogliflozin Etabonate For Sustained Antidiabetic Therapy.
Inventors include Ms. Ayushi Jain; and Dr. Akhlesh Kumar Singhai.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: The present invention relates to a polymeric transdermal drug delivery system incorporating Remogliflozin Etabonate for sustained treatment of diabetes mellitus. The transdermal patch comprises hydroxypropyl methylcellulose, Eudragit RLPO, Eudragit RSPO, a polyvinyl alcohol backing membrane, and ...